SkinBioTherapeutics plc (AIM:SBTX)

SkinBioTherapeutics Revenue

SkinBioTherapeutics had revenue of 2.17M GBP in the half year ending December 31, 2025, with 1,932.30% growth. This brings the company's total for the last twelve months to 5.23M, up 95.16% year-over-year. In the fiscal year ending June 30, 2025, SkinBioTherapeutics had annual revenue of 4.64M with 283.74% growth. That makes SkinBioTherapeutics the 38,812th largest company in the world by revenue and 750th in the United Kingdom.

• Revenue (ttm): 5.23M
• Revenue Growth: +95.16%
• P/S Ratio: 2.44
• Revenue / Employee: 127.50K
• Employees: 41
• Market Cap: 12.96M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United Kingdom 3.12M 67.4%
• Europe 1.22M 26.4%
• United States of America 147.49K 3.2%
• Rest of The World 143.96K 3.1%

Fiscal year ended Jun 30, 2025 See the full SkinBioTherapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	4.64M	3.43M	283.74%
Jun 30, 2024	1.21M	1.08M	815.26%
Jun 30, 2023	132.06K	57.30K	76.64%
Jun 30, 2022	74.76K	-	-
Jun 30, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 8, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 2, 2026

Data Sources Report a data error